Posted Mon, Nov, 07,2011
The Editor in Chief of Clinical Medical Insights: Oncology, Dr William C S Cho, has awarded an endorsement to 'Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T?'
In the endorsement the Editor in Chief writes:
Therapeutic advances changed dramatically in 2010 with the U.S. FDA approval of the autologous cellular immunotherapy sipuleucel-T for the treatment of men with asymptomatic or minimally symptomatic metastatic CRPC. This is an updated review on the data regarding therapeutic options with particular focus on the emerging strategies for incorporating sipuleucel-T into this changing landscape.
To read more visit the article now: Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T
Posted in: Editor in Chief Endorsed Articles
Fri 24 May, 2013Article Usage Metrics Now Available for all Journals
Fri 24 May, 2013Treatment of Recurrent HNSCC
Fri 24 May, 2013Bilateral Renal Infarction in a Lupus Patient
As the Editor-in-Chief of Clinical Medicine Insights: Trauma and Intensive Medicine, I experience an outstanding professional and timely support by the publisher, Libertas Academica, in all editorial matters.
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.See Our Results
Copyright © 2013 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)